Nicolas Leupin
Chief Tech/Sci/R&D Officer at NOVOCURE LIMITED
Net worth: 1 M $ as of 2024-05-30
Profile
Dr. Nicolas Leupin is a Chief Medical Officer at NovoCure Ltd.
Dr. Leupin was previously employed as a Chief Medical Officer by Molecular Partners AG, a Chief Medical Officer by argenx SE, and a Member by Swiss Group for Clinical Research.
He received his MBA from Jones International University and a doctorate degree from the University of Bern.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NOVOCURE LTD.
0.05% | 2024-02-26 | 51,124 ( 0.05% ) | 1 M $ | 2024-05-30 |
MOLECULAR PARTNERS AG
0.08% | 2023-12-30 | 29,168 ( 0.08% ) | 109 927 $ | 2024-05-30 |
Nicolas Leupin active positions
| Companies | Position | Start |
|---|---|---|
| NOVOCURE LIMITED | Chief Tech/Sci/R&D Officer | 2024-01-03 |
Former positions of Nicolas Leupin
| Companies | Position | End |
|---|---|---|
| MOLECULAR PARTNERS AG | Chief Tech/Sci/R&D Officer | 2023-08-23 |
| ARGENX SE | Chief Tech/Sci/R&D Officer | 2019-06-30 |
| Swiss Group for Clinical Research | Corporate Officer/Principal | - |
Training of Nicolas Leupin
| Jones International University | Masters Business Admin |
| University of Bern | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ARGENX SE | Health Technology |
| MOLECULAR PARTNERS AG | Health Technology |
| NOVOCURE LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
| Swiss Group for Clinical Research |
- Stock Market
- Insiders
- Nicolas Leupin
